Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.
Follow CHE
Chemed Corporation (CHE) EV/Sales
As of 16 October 2026, Chemed Corporation (CHE) trades at a EV/Sales of 2.6×. Over the past ten years it has ranged from 1.3× (January 2015) to 4.3× (March 2024); the current reading is higher than 37% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.4× | (24.56%) |
| FY2024 | 3.2× | (14.98%) |
| FY2023 | 3.8× | 7.28% |
| FY2022 | 3.6× | (10.44%) |
| FY2021 | 4.0× | (2.53%) |
| FY2020 | 4.1× | 10.47% |
| FY2019 | 3.7× | 41.54% |
| FY2018 | 2.6× | 7.05% |
| FY2017 | 2.4× | 39.57% |
| FY2016 | 1.7× | 3.35% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.4× | 16.48% |
| Mar 2026 | 2.1× | (15.62%) |
| Dec 2025 | 2.4× | (3.54%) |
| Sep 2025 | 2.5× | (8.44%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| UHS Universal Health Services, Inc. compare | 0.9× |
| OPCH Option Care Health, Inc. compare | 1.0× |
| PACS PACS Group, Inc. compare | 1.4× |
| ENSG The Ensign Group, Inc. compare | 1.8× |
| NHC National HealthCare Corporation compare | 2.3× |
| CHE Chemed Corporation | 2.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.7× |
| LFST LifeStance Health Group, Inc. compare | 2.9× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)